The moringa outbreak is over. The recalled powder may still be in cupboards.
The investigation closed at 131 reported cases across 38 states. Because the products last for years, that is not the same as the risk disappearing overnight.
Original image by Anecdotal
The investigation closed on 22 July 2026 after 131 reported infections, including 36 hospitalisations and no deaths. Recalled powders and capsules may still be in homes because their expiry dates run into 2028.
Why this matters
An outbreak can be declared over while the underlying products remain usable and stored. Consumers need the affected brands and lot guidance, not only the closure headline.
What the final update says
The FDA and CDC linked illnesses to recalled dietary supplements containing moringa leaf powder imported from India. Of 84 people interviewed across the investigation, 74 reported consuming a product containing moringa powder. Testing identified outbreak strains in finished products and ingredient samples.
The recalled list includes Live it Up Super Greens products and products from Why Not Natural and TNVitamins. Because some products carry expiry dates from August 2026 to January 2028, the FDA continues to tell consumers and retailers not to eat, sell or serve the affected products.
What changed—and what did not
The outbreak investigation is complete, which means investigators are no longer identifying ongoing illnesses connected to current exposure. It does not mean recalled stock has automatically disappeared. The FDA has increased screening of imported moringa powder from India for Salmonella.
Anyone checking a product should use the FDA page for the current brand, lot and expiry details. Anecdotal does not reproduce partial recall tables because they can change and should not replace the regulator’s live notice.
What this is based on
Summarised from the FDA’s final outbreak update.
Regulatory action · Independent
Sources
Go straight to the source.
- 01Outbreak Investigation of Salmonella: Moringa Leaf Powderregulator
US Food and Drug Administration · 2026-07-22
Stay in the loop.
The safety & regulation stories worth opening, in one weekly email.
We never sell or share your email. Unsubscribe in one click.
Keep reading
More like this.
FDA’s supplement import alert now covers more hidden drug ingredients
The July update reaches products sold for sexual enhancement, weight loss and muscle building—including formulas that may never make their real contents obvious.
FDA found undeclared stimulants in two Addall supplements
Testing found DMAA, DMHA and phenibut. Only one product was voluntarily recalled, which leaves an uncomfortable gap between finding and removal.
What the UK’s new supplement guidance changes for shoppers
The June update covers authorised claims, interactions and the line supplement labels cannot cross when they talk about symptoms.